Form 4: Verona Pharma CEO Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Verona Pharma's CEO, David Zaccardelli, disposed of shares to cover tax obligations related to vesting restricted share units.

Summary

  • David Zaccardelli, the President and CEO of Verona Pharma plc, disposed of 88,544 ordinary shares on May 1, 2024.
  • The transaction was executed to satisfy tax withholding obligations related to the vesting of previously reported Restricted Share Units.
  • The price per share was $1.9313, calculated based on the closing price of the Issuer's ADSs on the Nasdaq Stock Market LLC on April 30, 2024, divided by eight.
  • Following the transaction, Zaccardelli beneficially owns 15,854,048 ordinary shares.
  • These shares include 3,050,000 Ordinary Shares underlying Restricted Share Units and 12,804,048 Ordinary Shares underlying 1,600,506 ADSs.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction is a standard procedure for covering tax obligations related to executive compensation.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Stakeholder Impact

  • The transaction has a minimal impact on shareholders as it is related to tax obligations and does not indicate a change in the CEO's long-term commitment to the company.

Key Dates

DateDescription
04/30/2024Date used to calculate the price per share based on the closing price of Verona Pharma's ADSs on the Nasdaq Stock Market LLC.
05/01/2024Date of the transaction where David Zaccardelli disposed of shares.
05/03/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.